Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials
Reich K, Blauvelt A, Lebwohl M, Papp K, Rich P, Strober B, De Cuyper D, Madden C, Peterson L, Vanvoorden V, Warren R. Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. SKIN The Journal Of Cutaneous Medicine 2021, 5: s21. DOI: 10.25251/skin.5.supp.21.Peer-Reviewed Original Research